321 related articles for article (PubMed ID: 12796579)
1. Biologic predictors of survival in node-negative gastric cancer.
Kooby DA; Suriawinata A; Klimstra DS; Brennan MF; Karpeh MS
Ann Surg; 2003 Jun; 237(6):828-35; discussion 835-7. PubMed ID: 12796579
[TBL] [Abstract][Full Text] [Related]
2. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
3. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
4. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
5. Gastric cancer: establishing predictors of biologic behavior with use of population-based data.
Dicken BJ; Saunders LD; Jhangri GS; de Gara C; Cass C; Andrews S; Hamilton SM
Ann Surg Oncol; 2004 Jun; 11(6):629-35. PubMed ID: 15150070
[TBL] [Abstract][Full Text] [Related]
6. Significant prognostic factors in patients with early gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis after surgical treatment of gastric cancer: review of 121 cases.
Nazli O; Derici H; Tansug T; Yaman I; Bozdag AD; Isgüder AS; Bölükbasi H
Hepatogastroenterology; 2007 Mar; 54(74):625-9. PubMed ID: 17523337
[TBL] [Abstract][Full Text] [Related]
8. Is tumor size a prognostic indicator for gastric carcinoma?
Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
[TBL] [Abstract][Full Text] [Related]
9. Survival predictors in patients with node-negative gastric carcinoma.
Lee CC; Wu CW; Lo SS; Chen JH; Li AF; Hsieh MC; Shen KH; Lui WY
J Gastroenterol Hepatol; 2007 Jul; 22(7):1014-8. PubMed ID: 17608847
[TBL] [Abstract][Full Text] [Related]
10. Prognostic indicators in node-negative advanced gastric cancer patients.
Saito H; Kuroda H; Matsunaga T; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2010 Jun; 101(7):622-5. PubMed ID: 20461771
[TBL] [Abstract][Full Text] [Related]
11. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
12. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
[TBL] [Abstract][Full Text] [Related]
13. Early gastric cancer: univariate and multivariate analysis for survival.
Tuech JJ; Cervi C; Pessaux P; Villapadierna F; Bergamaschi R; Ronceray J; Arnaud JP
Hepatogastroenterology; 1999; 46(30):3276-80. PubMed ID: 10626201
[TBL] [Abstract][Full Text] [Related]
14. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
Piessen G; Messager M; Leteurtre E; Jean-Pierre T; Mariette C
Ann Surg; 2009 Dec; 250(6):878-87. PubMed ID: 19855261
[TBL] [Abstract][Full Text] [Related]
15. Re-study of gastric cancer: analysis of outcome.
Samson PS; Escovidal LA; Yrastorza SG; Veneracion RG; Nerves MY
World J Surg; 2002 Apr; 26(4):428-33. PubMed ID: 11910474
[TBL] [Abstract][Full Text] [Related]
16. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
17. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection.
Bentrem D; Wilton A; Mazumdar M; Brennan M; Coit D
Ann Surg Oncol; 2005 May; 12(5):347-53. PubMed ID: 15915368
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit?
Park SS; Park JM; Kim JH; Kim WB; Lee J; Kim SJ; Kim CS; Mok YJ
J Surg Oncol; 2006 Jul; 94(1):16-20. PubMed ID: 16788938
[TBL] [Abstract][Full Text] [Related]
19. Limited effectiveness of extended lymph-node dissection for node-negative patients with proximal gastric cancer.
Kikuchi S; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Sato K; Kakita A
Anticancer Res; 2001; 21(2B):1359-62. PubMed ID: 11396213
[TBL] [Abstract][Full Text] [Related]
20. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
